Clinical Trial Detail

NCT ID NCT03563716
Title A Study of MTIG7192A in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Genentech, Inc.
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab + MTIG7192A

Atezolizumab

Age Groups: adult senior

Additional content available in CKB BOOST